Oncolyze
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
666 3rd Ave, New York, New York, 10017, ...Website
www.oncolyze.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Oncolyze
Oncolyze is focused on developing a novel cancer therapeutic that targets and destroys cancer cells and cancer stem cells through a unique mechanism known as 'pop-tosis.' The company aims to provide hope for cancer patients by advancing their lead candidate, OM-301, across various cancer indications, including blood cancers and solid tumors. Oncolyze collaborates with leading academic and medical institutions to enhance their research and development efforts. Their mission is to ultimately cure cancer and make a life-changing impact on patients in need.Explore more
Oncolyze Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Oncolyze your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Oncolyze is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Oncolyze
Earning: See what the market has to say on Oncolyze recently announced quarterly report
Funding: Get notified immidiatlly once Oncolyze has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Oncolyze, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Oncolyze has recently received funding, and reach out quickly before it becomes old news!
Click to see if Oncolyze had a recent Job posting/layoffs
Product Launch: Get notified when Oncolyze launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Oncolyze
Compare insights from companies similar to Oncolyze, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Oncolyze is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Oncolyze is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Oncolyze.
Oncolyze Tech Stack
A closer look at the technologies used by Oncolyze
Oncolyze News & Media
TNG Creative Wins Two Prestigious Awards for an Integrated Marketing Campaign
TNG Creative, an award-winning, healthcare-focused, boutique consultancy, today announced that it has been awarded the 2023 IAC Award for Best Bi ...Oncolyze Launches an Equity Crowdfunding Campaign on StartEngine
Oncolyze has launched a Regulation A+ ("Reg A") funding campaign to spread awareness of OM-301 among cancer patients, healthcare professionals, a ...Oncolyze, a Company Aiming to Treat Cancer by Exploding Cancer Cells, is Now Accepting Investments. Own a Piece in the Future of Cancer Treatment.
NEW YORK, Aug. 23, 2022 (GLOBE NEWSWIRE) -- After successfully completing in vitro and in vivo (mice) experiments, which support the notion that its lead drug candidate OM-301 breaks down cancer cells and significantly increases survival rates, Oncolyze now has its sights set on advancing OM-301 into clinical trials.Oncolyze Announces FDA Orphan Drug Designation for OM-301 for the Treatment of Acute Myeloid Leukemia
NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Oncolyze, Inc, a biotech developing a disruptive technology for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted the company orphan drug designation for its pipeline compound OM-301 for the treatment of acute myeloid leukemia (AML). OM-301 is currently in pre-clinical development for AML and other cancers.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Oncolyze
Sign Up For FreeTo access detailed company insights
Oncolyze is focused on developing a novel cancer therapeutic that targets and destroys cancer cells and cancer stem cells through a unique mechanism known as 'pop-tosis.' The company aims to provide hope for cancer patients by advancing their lead candidate, OM-301, across various cancer indications, including blood cancers and solid tumors. Oncoly... Read More
